Genetic Variation in Prolactin and Breast Cancer Risk
Author Information
Author(s): Lee Sulggi A, Haiman Christopher A, Burtt Noel P, Pooler Loreall C, Cheng Iona, Kolonel Laurence N, Pike Malcolm C, Altshuler David, Hirschhorn Joel N, Henderson Brian E, Stram Daniel O
Primary Institution: Department of Preventive Medicine, University of Southern California
Hypothesis
Are genetic variations in PRL and PRLR associated with plasma PRL levels and breast cancer risk?
Conclusion
The study found no significant association between common genetic variations in PRL and PRLR genes and breast cancer risk or plasma PRL levels.
Supporting Evidence
- No significant associations were found between PRL and PRLR haplotypes or individual SNPs and breast cancer risk.
- A nominally significant association was noted between prolactin levels and a tagSNP in PRL, but it was not significant after correction for multiple testing.
- The study included a large multiethnic cohort, enhancing the diversity of the sample.
Takeaway
The researchers looked at genes related to prolactin to see if they affect breast cancer risk, but they didn't find any strong links.
Methodology
The study genotyped SNPs in PRL and PRLR genes in a multiethnic cohort and assessed their association with breast cancer risk and plasma PRL levels.
Limitations
The study may not be generalizable to premenopausal women and had a small sample size for some ethnic groups.
Participant Demographics
Participants included African-American, Native Hawaiian, Japanese-American, Latina, and White women.
Statistical Information
P-Value
0.002
Confidence Interval
1.00–2.18
Statistical Significance
p<0.0005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website